GPGA
VIVO

Grandeur Peak Global Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Grandeur Peak Global Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-78,028
Closed -$1.61M – 112
2014
Q2 		$1.61M Sell
78,028
-23,022
-23% -$473K 0.35% 75
2014
Q1 		$2.2M Sell
101,050
-8,500
-8% -$195K 0.52% 68
2013
Q4 		$2.91M Buy
109,550
+23,250
+27% +$571K 0.77% 53
2013
Q3 		$2.04M Sell
86,300
-6,700
-7% -$156K 0.57% 68
2013
Q2 		$2M Buy
+93,000
New +$2.01M 0.77% 50

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Grandeur Peak Global Advisors's VIVO Position: Q3 2014 in Review

Grandeur Peak Global Advisors sold out of Meridian Bioscience Inc (VIVO) in Q3 2014, closing a stake of 78,028 shares — an estimated $1.61M sold.

Grandeur Peak Global Advisors first reported a position in VIVO in Q2 2013 and held it in 5 quarters. The position peaked at $2.91M in Q4 2013. 161 funds tracked by Wall St. Rank hold VIVO as of Q3 2014.

  • Grandeur Peak Global Advisors reported no remaining Meridian Bioscience Inc position as of Q3 2014 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 78,028 Meridian Bioscience Inc shares in Q3 2014, an estimated $1.61M.
  • Grandeur Peak Global Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 5 quarters.
  • Grandeur Peak Global Advisors's Meridian Bioscience Inc position peaked at $2.91M in Q4 2013.
  • 161 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2014.

Based on Grandeur Peak Global Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.